Pharmacokinetics of Darunavir/Ritonavir With Etravirine Both Twice Daily in Human Immunodeficiency Virus-Infected Adolescents and Young Adults

Data on the combination of darunavir/ritonavir and etravirine both given twice daily in adolescents/young adults are lacking. In this study, we assessed the pharmacokinetics of darunavir/ritonavir 600/100 mg with etravirine 200 mg twice daily in 36 treatment-experienced human immunodeficiency virus-...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Pediatric Infect Dis Soc
Auteurs principaux: Cressey, Tim R, Yogev, Ram, Wiznia, Andrew, Hazra, Rohan, Jean-Philippe, Patrick, Graham, Bobbie, Gonzalez, Amy, Britto, Paula, Carey, Vincent J, Fletcher, Courtney V, Acosta, Edward P
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2017
Sujets:
Brief Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5907875/
https://ncbi.nlm.nih.gov/pubmed/27103489
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jpids/piw017
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires